Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)—A Meta-analysis

CONTEXT: The Afirma® GSC aids in risk stratifying indeterminate thyroid nodule cytology (ITN). The 2018 GSC validation study (VS) reported a sensitivity (SN) of 91%, specificity (SP) of 68%, positive predictive value (PPV) of 47%, and negative predictive value (NPV) of 96%. Since then, 13 independen...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasr, Christian E, Andrioli, Massimiliano, Endo, Mayumi, Harrell, R Mack, Livhits, Masha J, Osakwe, Ibitoro, Polavarapu, Preethi, Siperstein, Allan, Wei, Shuanzeng, Zheng, Xingyu, Jiang, Ruochen, Hao, Yangyang, Huang, J I ng, Klopper, Joshua P, Kloos, Richard T, Kennedy, Giulia, Angell, Trevor E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188305/
https://www.ncbi.nlm.nih.gov/pubmed/36470585
http://dx.doi.org/10.1210/clinem/dgac688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188305/
https://www.ncbi.nlm.nih.gov/pubmed/36470585
http://dx.doi.org/10.1210/clinem/dgac688

Ejemplares similares